Skip to Main Content

Author Details

Dexiang Gao
University of Colorado Anschutz Medical Campus
2001
142
38
PMIDPaper TitleJournal TitlePublished Year
36378549Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma.Clin Cancer Res2023
37828812Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low-income adults.Stat Med2023
37606183Integrated variant allele frequency analysis pipeline and R package: easyVAF.Mol Carcinog2023
35624328Adoption of Optimal Small (6-9 mm) Colorectal Polyp Resection Technique Over Time.Dig Dis Sci2023
37157185CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model.FEBS Open Bio2023
37389416The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma.J Natl Cancer Inst2023
37246777Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.Neuro Oncol2023
37210417Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.NPJ Breast Cancer2023
37142267Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE).J Natl Cancer Inst2023
37363965Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.Clin Cancer Res2023
37360690Interferon hyperactivity impairs cardiogenesis in Down syndrome via downregulation of canonical Wnt signaling.iScience2023
37197667<i>CTLA4</i> mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood <i>CTLA4</i> levels are associated with poor prognosis in metastatic melanoma patients.Front Immunol2023
36641932Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer.Lung Cancer2023
36726177Equivocal end-of-therapy imaging findings do not predict a higher risk of local relapse after definitive radiotherapy in pediatric Ewing sarcoma and rhabdomyosarcoma.Pediatr Blood Cancer2023
34767934Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy.Int J Radiat Oncol Biol Phys2022
35605559The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.Oral Oncol2022
35533965Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer.Eur J Pharm Sci2022
35366939Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.J Exp Clin Cancer Res2022
35525161Overall survival is the lowest among young women with postpartum breast cancer.Eur J Cancer2022
36100512The Effect of Intrathoracic Lesion Location on Initial Tyrosine Kinase Inhibitor Response in Advanced Oncogene-Addicted Non-Small Cell Lung Cancer: A Comparison Between RECIST 1.1 and a Novel Method of Response Assessment (MAX).Clin Lung Cancer2022
35961935Oncogene Overlap Analysis of Circulating Cell-free Tumor DNA to Explore the Appropriate Criteria for Defining MET Copy Number-Driven Lung Cancer.Clin Lung Cancer2022
34876360Gynecologic interstitial brachytherapy curriculum using a low-cost phantom with ultrasound workshop and a treatment planning workshop is effective.Brachytherapy2022
35332157Sexual dimorphic impacts of systemic vincristine on lower urinary tract function.Sci Rep2022
33414263Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.J Immunother Cancer2021
35990801Global melanoma correlations with obesity, smoking, and alcohol consumption.JMIR Dermatol2021
33540470A novel diphtheria toxin-based bivalent human EGF fusion toxin for treatment of head and neck squamous cell carcinoma.Mol Oncol2021
33674224A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma.Clin Genitourin Cancer2021
33816286Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials.Front Oncol2021
34218684Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.Clin Trials2021
34245214A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy.Pediatr Blood Cancer2021
34119517Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis.Gastroenterology2021
33436027Advanced adenomas may be a red flag for hereditary cancer syndromes.Hered Cancer Clin Pract2021
33087417Studying Immunotherapy Resistance in a Melanoma Autologous Humanized Mouse Xenograft.Mol Cancer Res2021
33069585Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort.Clin Genitourin Cancer2021
32353598Variation in Toxicity Reporting Methods for Early Phase Lung Cancer Treatment Trials at Oncology Conferences.J Thorac Oncol2020
31781896The impact of age at orchiopexy on testicular cancer outcomes.World J Urol2020
33088913Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer.NPJ Breast Cancer2020
33063469Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center.Cancer Med2020
32916850Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15<sup>+</sup> Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.Int J Mol Sci2020
32684283Reply to Letter to the Editor.J Pediatr Surg2020
32496550Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.JAMA Oncol2020
32409174Lymph node yield in pediatric, adolescent and young adult Renal Cell Carcinoma - How many are enough?J Pediatr Surg2020
30306797Algorithm to Predict Which Children With Chronic Abdominal Pain Are Low Suspicion for Significant Endoscopic Findings.Clin Pediatr (Phila)2019
31781510IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients.Front Oncol2019
31580832Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.Chem Biol Interact2019
31576334Extended follow-up on KEYNOTE-024 suggests significant survival benefit for pembrolizumab in patients with PD-L1 â¿¥50%, but unanswered questions remain.Ann Transl Med2019
31282194Obstructive Sleep Apnea and Sleep Position: Does It Matter for Infants With a Cleft Palate?Cleft Palate Craniofac J2019
31255328How many lymph nodes are enough? Assessing the adequacy of lymph node yield for staging in favorable histology wilms tumor.J Pediatr Surg2019
31099111Interleukin-37 is highly expressed in regulatory T cells of melanoma patients and enhanced by melanoma cell secretome.Mol Carcinog2019
30808730Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC.Mol Cancer Res2019
  • 1 - 50 of 142

Recommended Authors

Mayo Clinic
Career Start Year 2017
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 1
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 2011
Number of shared co-authors 0
Colleges of Medicine, University of Florida
Career Start Year 2009
Number of shared co-authors 0
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 1
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Career Start Year 2008
Number of shared co-authors 6
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
University of California
Career Start Year 2003
Number of shared co-authors 0
University of Virginia
Career Start Year 2002
Number of shared co-authors 0
McGill University
Career Start Year 2001
Number of shared co-authors 0
University of California san francisco
Career Start Year 2000
Number of shared co-authors 0
University of California San Diego
Career Start Year 2000
Number of shared co-authors 1
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 2
Stanford University
Career Start Year 1997
Number of shared co-authors 1
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 1
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year 1992
Number of shared co-authors 0
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 4
George Washington University
Career Start Year 1985
Number of shared co-authors 0
University of California davis
Career Start Year 1983
Number of shared co-authors 1
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Health Informatics Institute, University of South Florida
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Huntsman Cancer Institute, The University of Utah
Co-authored papers 13
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers 8
University of Colorado School of Medicine
Co-authored papers 8
University of Colorado School of Medicine
Co-authored papers 7
University of Colorado Denver
Co-authored papers 6
University of Colorado Anschutz Medical Campus
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
University of Colorado Anschutz Medical Campus
Co-authored papers 5
Stanford University
Co-authored papers 4
Rocky Mountain Regional Veterans Affairs Medical Center Aurora CO USA.
Co-authored papers 4
Co-authored papers 4
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Geisel School of Medicine at Dartmouth
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Emory University School of Medicine
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
University of Colorado School of Medicine
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Co-authored papers 2
University of California san francisco
Co-authored papers 2
College of Medicine, University of Florida
Co-authored papers 1
University of Colorado Division of Hematology
Co-authored papers 1
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
University of California San Diego
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1